Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 31Myelodysplastic Syndromes 26Multiple Myeloma 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia 19Lymphoma 18Hodgkin Disease 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Lymphoma, Non-Hodgkin 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Large B-Cell, Diffuse 10Hematologic Neoplasms 9Primary Myelofibrosis 8Leukemia, Myelomonocytic, Chronic 8Graft vs Host Disease 8Myeloproliferative Disorders 7Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Leukemia, Myelomonocytic, Juvenile 5Recurrence 4Neoplasms 4Lymphoma, T-Cell 4Lymphoma, B-Cell, Marginal Zone 4Burkitt Lymphoma 4Breast Neoplasms 4Anemia, Aplastic 4Polycythemia Vera 3Lymphoma, Mantle-Cell 3Leukemia, Biphenotypic, Acute 3Hemoglobinuria, Paroxysmal 3

Interventions

fludarabine phosphate 2Whole-Body Irradiation 2Mycophenolic Acid 2letermovir 1carmustine, poliferprosan 20 drug combination 1Tacrolimus 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Hematopoietic Stem Cell Transplantation 1Etoposide 1Cytarabine 1Cyclosporins 1Cyclosporine 1Cyclophosphamide 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Prolymphocytic, B-Cell × Stem Cell Transplantation × Clear all
NCT00060424 2017-12-08

Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia

Fred Hutchinson Cancer Center

Phase 2 Completed
21 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, Leukemia, Prolymphocytic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡